Atlas Trials

Open-label, Post-marketing, Prospective Study to Assess Impact of COVID-19 on Cognitive Function in Patients

Clinical trial NCT04950673 · UNKNOWN

Trial details

NCT number
NCT04950673
Sponsor
Cognivue, Inc.
Status
UNKNOWN
Study type
OBSERVATIONAL
Cognitive DeclineCognitive DysfunctionBrain HealthPost CoV-2 SyndromeCOVID Long-Haul
Start date
2021-07-21
Primary completion
2023-11-30
Enrollment
1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.